{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T07:26:54Z","timestamp":1751614014157},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T00:00:00Z","timestamp":1231286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Dermatol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-5945-9-1","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T07:13:43Z","timestamp":1231398823000},"source":"Crossref","is-referenced-by-count":4,"title":["Mutation analysis of the Gadd45 gene at exon 4 in atypical fibroxanthoma"],"prefix":"10.1186","volume":"9","author":[{"given":"Akio","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuka","family":"Akieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihide","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masazumi","family":"Tsuneyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,7]]},"reference":[{"key":"82_CR1","first-page":"183","volume":"84","author":"I Dahl","year":"1976","unstructured":"Dahl I: Atypical fibroxanthoma of the skin. A clinico-pathological study of 57 cases. Acta Pathol Microbiol Scand [A] 1976, 84: 183\u2013197.","journal-title":"Acta Pathol Microbiol Scand [A]"},{"key":"82_CR2","volume-title":"Soft tissue tumors","author":"FM Enzinger","year":"1995","unstructured":"Enzinger FM, Weiss SW: Soft tissue tumors. St. Louis: CV Mosby; 1995."},{"key":"82_CR3","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/1097-0142(197306)31:6<1541::AID-CNCR2820310635>3.0.CO;2-6","volume":"31","author":"DF Fretzin","year":"1973","unstructured":"Fretzin DF, Helwig EB: Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973, 31: 1541\u20131552. Publisher Full Text 10.1002\/1097-0142(197306)31:6<1541::AID-CNCR2820310635>3.0.CO;2-6","journal-title":"Cancer"},{"key":"82_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2559.1993.tb00114.x","volume":"22","author":"E Calonje","year":"1993","unstructured":"Calonje E, Wadden C, Wilson-Jones E, Fletcher CD: Spindle-cell non-pleomorphic atypical fibroxanthoma: analysis of a series and delineation of a distinctive variant. Histopathology 1993, 22: 247\u2013254. 10.1111\/j.1365-2559.1993.tb00114.x","journal-title":"Histopathology"},{"key":"82_CR5","first-page":"11","volume":"145","author":"AP Dei Tos","year":"1994","unstructured":"Dei Tos AP, Maestro R, Doglioni C, Gasparotto D, Boiocchi M, Laurino L, Fletcher CD: Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 1994, 145: 11\u201317.","journal-title":"Am J Pathol"},{"key":"82_CR6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1101\/gad.10.9.1054","volume":"10","author":"LJ Ko","year":"1996","unstructured":"Ko LJ, Prives C: p53: puzzle and paradigm. Genes Dev 1996, 10: 1054\u20131072. 10.1101\/gad.10.9.1054","journal-title":"Genes Dev"},{"key":"82_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbamcr.2003.08.009","volume":"1644","author":"V Kirkin","year":"2004","unstructured":"Kirkin V, Joos S, Zornig M: The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 2004, 1644: 229\u2013249. 10.1016\/j.bbamcr.2003.08.009","journal-title":"Biochim Biophys Acta"},{"key":"82_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/385637a0","volume":"385","author":"C Yin","year":"1997","unstructured":"Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T: Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 1997, 385: 637\u2013640. 10.1038\/385637a0","journal-title":"Nature"},{"key":"82_CR9","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1523\/JNEUROSCI.18-04-01363.1998","volume":"18","author":"H Xiang","year":"1998","unstructured":"Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Schwartzkroin PA, Morrison RS: Bax involvement in p53-mediated neuronal cell death. J Neurosci 1998, 18: 1363\u20131373.","journal-title":"J Neurosci"},{"key":"82_CR10","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1073\/pnas.96.7.3706","volume":"96","author":"XW Wang","year":"1999","unstructured":"Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace AJ Jr, Harris CC: GADD45 induction of a G2\/M cell cycle checkpoint. Proc Natl Acad Sci USA 1999, 96: 3706\u20133711. 10.1073\/pnas.96.7.3706","journal-title":"Proc Natl Acad Sci USA"},{"key":"82_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/13802","volume":"23","author":"MC Hollander","year":"1999","unstructured":"Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, et al.: Genomic instability in Gadd45a-deficient mice. Nat Genet 1999, 23: 176\u2013184. 10.1038\/13802","journal-title":"Nat Genet"},{"key":"82_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0092-8674(00)80769-2","volume":"97","author":"DP Harkin","year":"1999","unstructured":"Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA: Induction of GADD45 and JNK\/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 1999, 97: 575\u2013586. 10.1016\/S0092-8674(00)80769-2","journal-title":"Cell"},{"key":"82_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/BF02267084","volume":"97","author":"H Blaszyk","year":"1996","unstructured":"Blaszyk H, Hartmann A, Sommer SS, Kovach JS: A polymorphism but no mutations in the GADD45 gene in breast cancers. Hum Genet 1996, 97: 543\u2013547. 10.1007\/BF02267084","journal-title":"Hum Genet"},{"key":"82_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1046\/j.1365-2184.2000.00187.x","volume":"33","author":"P Campomenosi","year":"2000","unstructured":"Campomenosi P, Hall PA: Gadd45 mutations are uncommon in human tumour cell lines. Cell Prolif 2000, 33: 301\u2013306. 10.1046\/j.1365-2184.2000.00187.x","journal-title":"Cell Prolif"},{"key":"82_CR15","first-page":"2563","volume":"8","author":"K Yamasawa","year":"2002","unstructured":"Yamasawa K, Nio Y, Dong M, Yamaguchi K, Itakura M: Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer. Clin Cancer Res 2002, 8: 2563\u20132569.","journal-title":"Clin Cancer Res"},{"key":"82_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1365-2559.2007.02685.x","volume":"50","author":"A Sakamoto","year":"2007","unstructured":"Sakamoto A, Oda Y, Tsuneyoshi M, Iwamoto Y: Expression of the UV-induced molecule, Gadd45, in atypical fibroxanthoma. Histopathology 2007, 50: 939\u2013941. 10.1111\/j.1365-2559.2007.02685.x","journal-title":"Histopathology"},{"key":"82_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/modpathol.3880354","volume":"14","author":"A Sakamoto","year":"2001","unstructured":"Sakamoto A, Oda Y, Itakura E, Oshiro Y, Nikaido O, Iwamoto Y, Tsuneyoshi M: Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma. Mod Pathol 2001, 14: 581\u2013588. 10.1038\/modpathol.3880354","journal-title":"Mod Pathol"},{"key":"82_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1183\/09031936.02.00219402","volume":"19","author":"C Gessner","year":"2002","unstructured":"Gessner C, Liebers U, Kuhn H, Stiehl P, Witt C, Schauer J, Wolff G: BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer. Eur Respir J 2002, 19: 134\u2013140. 10.1183\/09031936.02.00219402","journal-title":"Eur Respir J"},{"key":"82_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ygyno.2003.08.038","volume":"92","author":"XQ Zhu","year":"2004","unstructured":"Zhu XQ, Shi YF, Cheng XD, Zhao CL, Wu YZ: Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Gynecol Oncol 2004, 92: 71\u201379. 10.1016\/j.ygyno.2003.08.038","journal-title":"Gynecol Oncol"},{"key":"82_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1083\/jcb.140.1.171","volume":"140","author":"Y Aragane","year":"1998","unstructured":"Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger TA, Schwarz T: Ultraviolet light induces apoptosis via direct activation of CD95 (Fas\/APO-1) independently of its ligand CD95L. J Cell Biol 1998, 140: 171\u2013182. 10.1083\/jcb.140.1.171","journal-title":"J Cell Biol"},{"key":"82_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 2000, 408: 307\u2013310. 10.1038\/35042675","journal-title":"Nature"},{"key":"82_CR22","doi-asserted-by":"publisher","first-page":"6784","DOI":"10.1038\/sj.onc.1204883","volume":"20","author":"L Latonen","year":"2001","unstructured":"Latonen L, Taya Y, Laiho M: UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts. Oncogene 2001, 20: 6784\u20136793. 10.1038\/sj.onc.1204883","journal-title":"Oncogene"},{"key":"82_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2133.2000.03721.x","volume":"143","author":"FH Dilek","year":"2000","unstructured":"Dilek FH, Akpolat N, Metin A, Ugras S: Atypical fibroxanthoma of the skin and the lower lip in xeroderma pigmentosum. Br J Dermatol 2000, 143: 618\u2013620. 10.1111\/j.1365-2133.2000.03721.x","journal-title":"Br J Dermatol"},{"key":"82_CR24","volume-title":"Skin Pathology","author":"D Weedon","year":"2002","unstructured":"Weedon D, Strutton G: Skin Pathology. 2nd edition. London: Elsevier Science; 2002.","edition":"2"},{"key":"82_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1525-1438.2005.15308.x","volume":"15","author":"H Lee","year":"2005","unstructured":"Lee H, Park G, Jung JH, Ahn WS, Lee JM, Kim BK, Kang CS: Diagnostic approach using the expression profiling of the P53 tumor suppressor gene and its related proteins in ovarian epithelial tumors. Int J Gynecol Cancer 2005, 15: 453\u2013461. 10.1111\/j.1525-1438.2005.15308.x","journal-title":"Int J Gynecol Cancer"},{"key":"82_CR26","first-page":"2233","volume":"17","author":"D Marx","year":"1997","unstructured":"Marx D, Binder C, Meden H, Lenthe T, Ziemek T, Hiddemann T, Kuhn W, Schauer A: Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer. Anticancer Res 1997, 17: 2233\u20132240.","journal-title":"Anticancer Res"},{"key":"82_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00000372-199706000-00005","volume":"19","author":"FN Westermann","year":"1997","unstructured":"Westermann FN, Langlois NE, Simpson JG: Apoptosis in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma. Am J Dermatopathol 1997, 19: 228\u2013231. 10.1097\/00000372-199706000-00005","journal-title":"Am J Dermatopathol"},{"key":"82_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2834.2002.00310.x","volume":"10","author":"M Osaki","year":"2002","unstructured":"Osaki M, Osaki M, Yamashita H, Shomori K, Yoshida H, Ito H: Expression of minichromosome maintenance-2 in human malignant fibrous histiocytomas: Correlations with Ki-67 and P53 expression, and apoptosis. Int J Mol Med 2002, 10: 161\u2013168.","journal-title":"Int J Mol Med"},{"key":"82_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.0303-6987.2004.00173.x","volume":"31","author":"MJ Smith-Zagone","year":"2004","unstructured":"Smith-Zagone MJ, Prieto VG, Hayes RA, Timperman WW Jr, Diwan AH: HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report. J Cutan Pathol 2004, 31: 284\u2013286. 10.1111\/j.0303-6987.2004.00173.x","journal-title":"J Cutan Pathol"},{"key":"82_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1600-0560.2006.00635.x","volume":"34","author":"TL Hultgren","year":"2007","unstructured":"Hultgren TL, DiMaio DJ: Immunohistochemical staining of CD10 in atypical fibroxanthomas. J Cutan Pathol 2007, 34: 415\u2013419. 10.1111\/j.1600-0560.2006.00635.x","journal-title":"J Cutan Pathol"},{"key":"82_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/01.dad.0000150766.74493.19","volume":"27","author":"D Weedon","year":"2005","unstructured":"Weedon D, Williamson R, Mirza B: CD10, a useful marker for atypical fibroxanthomas. Am J Dermatopathol 2005, 27: 181. 10.1097\/01.dad.0000150766.74493.19","journal-title":"Am J Dermatopathol"},{"key":"82_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1600-0560.2006.00492.x","volume":"33","author":"PH Hartel","year":"2006","unstructured":"Hartel PH, Jackson J, Ducatman BS, Zhang P: CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker. J Cutan Pathol 2006, 33: 24\u201328. 10.1111\/j.1600-0560.2006.00492.x","journal-title":"J Cutan Pathol"},{"key":"82_CR33","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2115::AID-CNCR8>3.0.CO;2-N","volume":"79","author":"R Lazova","year":"1997","unstructured":"Lazova R, Moynes R, May D, Scott G: LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer 1997, 79: 2115\u20132124. 10.1002\/(SICI)1097-0142(19970601)79:11<2115::AID-CNCR8>3.0.CO;2-N","journal-title":"Cancer"},{"key":"82_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1600-0560.1993.tb00645.x","volume":"20","author":"JT Worrell","year":"1993","unstructured":"Worrell JT, Ansari MQ, Ansari SJ, Cockerell CJ: Atypical fibroxanthoma: DNA ploidy analysis of 14 cases with possible histogenetic implications. J Cutan Pathol 1993, 20: 211\u2013215. 10.1111\/j.1600-0560.1993.tb00645.x","journal-title":"J Cutan Pathol"},{"key":"82_CR35","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/1097-0142(19950301)75:5<1128::AID-CNCR2820750512>3.0.CO;2-H","volume":"75","author":"Y Oshiro","year":"1995","unstructured":"Oshiro Y, Fukuda T, Tsuneyoshi M: Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining. Cancer 1995, 75: 1128\u20131134. Publisher Full Text 10.1002\/1097-0142(19950301)75:5<1128::AID-CNCR2820750512>3.0.CO;2-H","journal-title":"Cancer"},{"key":"82_CR36","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1053\/hupa.2001.28953","volume":"32","author":"A Sakamoto","year":"2001","unstructured":"Sakamoto A, Oda Y, Itakura E, Oshiro Y, Tamiya S, Honda Y, Ishihara A, Iwamoto Y, Tsuneyoshi M: H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma. Hum Pathol 2001, 32: 1225\u20131231. 10.1053\/hupa.2001.28953","journal-title":"Hum Pathol"},{"key":"82_CR37","doi-asserted-by":"publisher","first-page":"15693","DOI":"10.1021\/bi962117z","volume":"35","author":"S Tommasi","year":"1996","unstructured":"Tommasi S, Swiderski PM, Tu Y, Kaplan BE, Pfeifer GP: Inhibition of transcription factor binding by ultraviolet-induced pyrimidine dimers. Biochemistry 1996, 35: 15693\u201315703. 10.1021\/bi962117z","journal-title":"Biochemistry"}],"container-title":["BMC Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-5945-9-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-5945-9-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-5945-9-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T15:33:47Z","timestamp":1632929627000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcdermatol.biomedcentral.com\/articles\/10.1186\/1471-5945-9-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1186\/1471-5945-9-1","relation":{},"ISSN":["1471-5945"],"issn-type":[{"value":"1471-5945","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,7]]},"article-number":"1"}}